Synapse - Mark Kris

Results (873)

Microarray gene expression analysis of cells isolated from malignant pleural effusions (MPE) from patients with non-small cell lung cancer (NSCLC)

Meeting Abstract

Park, B. J.; Bhattacharya, S.; Azzoli, C.; Rusch, V.; Kris, M.; Ghossein, R.
Journal of Clinical Oncology (2004)

Fulltext@MSK | Save

Molecular characteristics of non-small cell lung cancer (NSCLC) patients sensitive to gefitinib

Meeting Abstract

Pao, W.; Zakowski, M.; Cordon-Cardo, C.; Ben-Porat, L.; Kris, M. G.; Miller, V. A.
Journal of Clinical Oncology (2004)

Fulltext@MSK | Save

Elucidating mechanisms of resistance to EGFR tyrosine kinase inhibitors in non-small cell lung cancer (NSCLC)

Meeting Abstract

Pao, W.; Miller, V. A.; Kris, M. G.; Varmus, H. E.
Annals of Oncology (2004)

Fulltext@MSK | Save

Brain and leptomeningeal metastases in non-small cell lung cancer (NSCLC) responsive to Gefitinib: Is the CNS being left behind?

Meeting Abstract

Omuro, A. M. P.; Franceschi, E.; Kris, M. G.; Miller, V. A.; Shah, N.; Abrey, L. E.
Neuro-Oncology (2004)

Fulltext@MSK | Save

Brain and leptomeningeal metastases in nonsmall cell lung cancer (NSCLC) responsive to Gefitinib

Meeting Abstract

Milton, D. T.; Omuro, A. M. P.; Shah, N.; Franceschi, E.; Abrey, L. E.; Miller, V. A.; Kris, M. G.
Lung Cancer (2004)

Fulltext@MSK | Save

Weekly high-dose erlotinib in patients with non-small cell lung cancer (NSCLC): A phase I/II study

Meeting Abstract

Milton, D. T.; Miller, V. A.; Azzoli, C. G.; Dunne, M.; Gomez, J. E.; Heelan, R.; Krug, L. M.; Ramies, D.; Rizvi, N. A.; Kris, M. G.
Journal of Clinical Oncology (2004)

Fulltext@MSK | Save

Long survival of never smoking non-small cell lung cancer (NSCLC) patients (pts) treated with erlotinib HCI (OSI-774) and chemotherapy: Sub-group analysis of TRIBUTE

Meeting Abstract

Miller, V. A.; Herbst, R.; Prager, D.; Fehrenbacher, L.; Hermann, R.; Hoffman, P.; Johnson, B.; Sandler, A. B.; Kris, M. G.; Ramies, D.
Journal of Clinical Oncology (2004)

Fulltext@MSK | Save

C-kit protein expression in tumor specimens as a predictor of sensitivity to imatinib mesylate in patients with small cell lung cancer (SCLC): A phase II clinical trial

Meeting Abstract

Krug, L. M.; Crapanzano, J. P.; Miller, V. A.; Azzoli, C. G.; Rizvi, N.; Gomez, J.; Pizzo, B.; Tyson, L.; Dunne, M.; Kris, M. G.
Journal of Clinical Oncology (2004)

Fulltext@MSK | Save

Cigarette smoking history predicts sensitivity to erlotinib: Results of a phase II trial in patients with bronchioloalveolar carcinoma (BAC)

Meeting Abstract

Kris, M. G.; Sandler, A.; Miller, V.; Cespon, M.; Zakowski, M.; Pizzo, B.; Venkatraman, E.; Gomez, J.; Johnson, D.; Carbone, D.
Journal of Clinical Oncology (2004)

Fulltext@MSK | Save

Inhibitors of the epidermal growth factor receptor tyrosine kinase: targeted therapy hits the Bullseye in patients with non-small-cell lung cancer

Meeting Abstract

Kris, M. G.
Lung Cancer (2004)

Fulltext@MSK | Save